BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Buys 9,132 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 59.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,613 shares of the company’s stock after acquiring an additional 9,132 shares during the quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Henry Schein were worth $1,578,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in HSIC. Marshall Wace LLP purchased a new stake in shares of Henry Schein in the second quarter valued at approximately $851,000. Bank of Montreal Can lifted its position in Henry Schein by 6.7% during the second quarter. Bank of Montreal Can now owns 152,798 shares of the company’s stock valued at $10,320,000 after acquiring an additional 9,596 shares during the last quarter. Magnetar Financial LLC lifted its holdings in shares of Henry Schein by 32.1% during the 2nd quarter. Magnetar Financial LLC now owns 510,610 shares of the company’s stock valued at $32,730,000 after purchasing an additional 124,152 shares during the last quarter. Public Sector Pension Investment Board boosted its holdings in Henry Schein by 64.9% in the second quarter. Public Sector Pension Investment Board now owns 4,936 shares of the company’s stock worth $316,000 after acquiring an additional 1,942 shares in the last quarter. Finally, ProShare Advisors LLC boosted its stake in Henry Schein by 6.6% in the 2nd quarter. ProShare Advisors LLC now owns 18,860 shares of the company’s stock worth $1,209,000 after purchasing an additional 1,165 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the topic of several recent research reports. UBS Group dropped their price objective on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. Piper Sandler reissued an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a report on Friday, June 21st. Evercore ISI dropped their target price on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a research report on Wednesday, August 7th. JPMorgan Chase & Co. dropped their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research note on Friday, September 20th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $77.10.

Insider Transactions at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Trading Up 3.3 %

Shares of HSIC stock opened at $73.22 on Monday. The company has a 50-day moving average of $70.10 and a two-hundred day moving average of $70.18. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The firm has a market cap of $9.38 billion, a PE ratio of 24.74, a price-to-earnings-growth ratio of 2.01 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, beating the consensus estimate of $1.22 by $0.01. The company had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm’s revenue was up .0% compared to the same quarter last year. During the same quarter last year, the company posted $1.31 EPS. On average, analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.